Paper Details

  1. Home
  2. Paper Details

Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia.

Author: BastianL, HaberthürR, MenterT, Rätz BravoA E, SchlageterM, TzankovA

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This article reports the first documented case of an azacitidine-associated lymphoproliferative disease resembling polymorphic post-transplant lymphoproliferative disease. The case highlights the potential for iatrogenic lymphoproliferative disorders associated with certain chemotherapeutic agents.
Paper Details　
Original Abstract of the Article :
Some chemotherapeutic agents can cause iatrogenic lymphoproliferative disorders. In analogy to what has been observed with other nucleoside analogues such as cladribine and fludarabine, we document the first case of an Epstein-Barr virus-positive, iatrogenic immunodeficiency-associated, lymphoprolif...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/hon.2054

データ提供：米国国立医学図書館（NLM）

Azacitidine-Associated Lymphoproliferative Disorder: A Case Report

The use of chemotherapeutic agents can have both intended and unintended consequences. This case report highlights a rare complication of azacitidine, a drug used to treat chronic myelomonocytic leukemia (CMML). The authors describe the development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient who was treated with azacitidine, much like an unexpected desert storm that can disrupt the delicate balance of an ecosystem.

Understanding the Potential Complications of Azacitidine

This case report provides valuable insights into the potential adverse effects of azacitidine. It underscores the importance of careful monitoring and vigilance in patients receiving this treatment. The authors suggest that oncologists and pathologists should be aware of this potential complication.

Navigating the Complexities of Cancer Treatment

This research highlights the complex and unpredictable nature of cancer treatment. It's like navigating a vast desert: there are many potential challenges and unexpected turns along the way. It's crucial for healthcare providers to be aware of the potential risks and benefits of each treatment option.

Dr.Camel's Conclusion

This case report reminds us that even the most effective treatments can have unintended consequences. It's like navigating a desert: we need to be prepared for unforeseen challenges and ready to adjust our course as needed.

Date :
  1. Date Completed 2014-04-25
  2. Date Revised 2014-03-05
Further Info :

Pubmed ID

23625339

DOI: Digital Object Identifier

10.1002/hon.2054

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.